BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Sep 03, 2007
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Cara Therapeutics Inc.

Shelton, Conn.

Technology: Kappa opioid receptor agonists and GPCR DimerScreen technology

Disease focus: Neurology,...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >